Vaxcyte Announces Pricing of $750 Million Public Offering - Vaxcyte (NASDAQ:PCVX)

Benzinga

Center

High Factuality

Vaxcyte Announces Pricing of $750 Million Public Offering - Vaxcyte (NASDAQ:PCVX)

SAN CARLOS, Calif., Jan. 30, 2024 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (NASDAQ:PCVX), a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, announced today the pricing of an underwritten public offering of common stock and pre-funded warrants. Vaxcyte is selling 10,937,500 shares of common stock and pre-funded warrants to purchase 781,250 shares of common s…